0 XP   0   0   0

Thyrocare Technologies Ltd
Buy, Hold or Sell?

Should you buy, hold or sell Thyrocare?

I guess you are interested in Thyrocare Technologies Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Thyrocare

Let's start. I'm going to help you getting a better view of Thyrocare Technologies Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Thyrocare Technologies Ltd even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Thyrocare Technologies Ltd is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Thyrocare Technologies Ltd. The closing price on 2023-02-08 was INR488.85 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Thyrocare Technologies Ltd Daily Candlestick Chart
Thyrocare Technologies Ltd Daily Candlestick Chart
Summary









1. Valuation of Thyrocare




Current price per share

INR488.85

2. Growth of Thyrocare




Is Thyrocare growing?

Current yearPrevious yearGrowGrow %
How rich?$63.7m$51.7m$12m18.9%

How much money is Thyrocare making?

Current yearPrevious yearGrowGrow %
Making money$21.3m$13.6m$7.6m35.8%
Net Profit Margin29.9%22.9%--

How much money comes from the company's main activities?

3. Financial Health of Thyrocare




Comparing to competitors in the Diagnostics & Research industry




  Industry Rankings (Diagnostics & Research)  


Richest
#86 / 171

Most Revenue
#71 / 171

Most Profit
#44 / 171


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Thyrocare Technologies Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Thyrocare earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Thyrocare to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 29.9% means that ₹0.30 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Thyrocare Technologies Ltd:

  • The MRQ is 29.9%. The company is making a huge profit. +2
  • The TTM is 29.9%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ29.9%TTM29.9%0.0%
TTM29.9%YOY22.9%+7.0%
TTM29.9%5Y24.1%+5.8%
5Y24.1%10Y24.5%-0.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ29.9%-7.3%+37.2%
TTM29.9%-4.9%+34.8%
YOY22.9%0.5%+22.4%
5Y24.1%-5.8%+29.9%
10Y24.5%-3.4%+27.9%
1.1.2. Return on Assets

Shows how efficient Thyrocare is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Thyrocare to the Diagnostics & Research industry mean.
  • 29.0% Return on Assets means that Thyrocare generated ₹0.29 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Thyrocare Technologies Ltd:

  • The MRQ is 29.0%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is 29.0%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ29.0%TTM29.0%0.0%
TTM29.0%YOY20.7%+8.3%
TTM29.0%5Y21.2%+7.8%
5Y21.2%10Y18.6%+2.6%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ29.0%-0.5%+29.5%
TTM29.0%-0.4%+29.4%
YOY20.7%0.2%+20.5%
5Y21.2%-0.8%+22.0%
10Y18.6%-0.8%+19.4%
1.1.3. Return on Equity

Shows how efficient Thyrocare is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Thyrocare to the Diagnostics & Research industry mean.
  • 33.5% Return on Equity means Thyrocare generated ₹0.33 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Thyrocare Technologies Ltd:

  • The MRQ is 33.5%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 33.5%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ33.5%TTM33.5%0.0%
TTM33.5%YOY26.5%+7.0%
TTM33.5%5Y24.9%+8.5%
5Y24.9%10Y21.7%+3.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ33.5%0.7%+32.8%
TTM33.5%0.3%+33.2%
YOY26.5%0.6%+25.9%
5Y24.9%-1.3%+26.2%
10Y21.7%-1.8%+23.5%

1.2. Operating Efficiency of Thyrocare Technologies Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Thyrocare is operating .

  • Measures how much profit Thyrocare makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Thyrocare to the Diagnostics & Research industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Thyrocare Technologies Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y20.1%-20.1%
5Y20.1%10Y26.6%-6.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.3%-0.3%
TTM--1.8%+1.8%
YOY-1.1%-1.1%
5Y20.1%-2.5%+22.6%
10Y26.6%-1.6%+28.2%
1.2.2. Operating Ratio

Measures how efficient Thyrocare is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.95 means that the operating costs are ₹0.95 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Thyrocare Technologies Ltd:

  • The MRQ is 0.947. The company is less efficient in keeping operating costs low.
  • The TTM is 0.947. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.947TTM0.9470.000
TTM0.947YOY1.046-0.099
TTM0.9475Y0.961-0.015
5Y0.96110Y0.988-0.027
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9471.329-0.382
TTM0.9471.234-0.287
YOY1.0461.234-0.188
5Y0.9611.103-0.142
10Y0.9881.031-0.043

1.3. Liquidity of Thyrocare Technologies Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Thyrocare is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 4.19 means the company has ₹4.19 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Thyrocare Technologies Ltd:

  • The MRQ is 4.185. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.185. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.185TTM4.1850.000
TTM4.185YOY2.504+1.681
TTM4.1855Y4.435-0.250
5Y4.43510Y7.799-3.364
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1852.412+1.773
TTM4.1852.617+1.568
YOY2.5042.767-0.263
5Y4.4352.626+1.809
10Y7.7992.837+4.962
1.3.2. Quick Ratio

Measures if Thyrocare is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Thyrocare to the Diagnostics & Research industry mean.
  • A Quick Ratio of 3.39 means the company can pay off ₹3.39 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Thyrocare Technologies Ltd:

  • The MRQ is 3.385. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.385. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.385TTM3.3850.000
TTM3.385YOY1.595+1.790
TTM3.3855Y3.158+0.227
5Y3.15810Y6.077-2.919
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3851.321+2.064
TTM3.3851.454+1.931
YOY1.5951.515+0.080
5Y3.1581.553+1.605
10Y6.0771.530+4.547

1.4. Solvency of Thyrocare Technologies Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Thyrocare assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Thyrocare to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.13 means that Thyrocare assets are financed with 13.3% credit (debt) and the remaining percentage (100% - 13.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Thyrocare Technologies Ltd:

  • The MRQ is 0.133. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.133. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.133TTM0.1330.000
TTM0.133YOY0.217-0.084
TTM0.1335Y0.145-0.012
5Y0.14510Y0.124+0.022
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1330.404-0.271
TTM0.1330.404-0.271
YOY0.2170.433-0.216
5Y0.1450.453-0.308
10Y0.1240.442-0.318
1.4.2. Debt to Equity Ratio

Measures if Thyrocare is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Thyrocare to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 15.4% means that company has ₹0.15 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Thyrocare Technologies Ltd:

  • The MRQ is 0.154. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.154. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.154TTM0.1540.000
TTM0.154YOY0.277-0.123
TTM0.1545Y0.177-0.023
5Y0.17710Y0.147+0.029
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1540.598-0.444
TTM0.1540.620-0.466
YOY0.2770.672-0.395
5Y0.1770.753-0.576
10Y0.1470.741-0.594

2. Market Valuation of Thyrocare Technologies Ltd

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Thyrocare generates.

  • Above 15 is considered overpriced but always compare Thyrocare to the Diagnostics & Research industry mean.
  • A PE ratio of 23.24 means the investor is paying ₹23.24 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Thyrocare Technologies Ltd:

  • The EOD is 14.683. Very good. +2
  • The MRQ is 23.239. Very good. +2
  • The TTM is 23.239. Very good. +2
Trends
Current periodCompared to+/- 
EOD14.683MRQ23.239-8.557
MRQ23.239TTM23.2390.000
TTM23.239YOY42.194-18.955
TTM23.2395Y32.428-9.189
5Y32.42810Y27.987+4.441
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD14.683-1.994+16.677
MRQ23.239-2.312+25.551
TTM23.239-4.930+28.169
YOY42.194-0.548+42.742
5Y32.428-1.611+34.039
10Y27.987-1.973+29.960
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Thyrocare.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Thyrocare Technologies Ltd:

  • The MRQ is 14.937. Seems overpriced? -1
  • The TTM is 14.937. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ14.937TTM14.9370.000
TTM14.937YOY32.992-18.056
TTM14.9375Y25.468-10.531
5Y25.46810Y39.610-14.142
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ14.937-0.052+14.989
TTM14.9370.036+14.901
YOY32.9920.113+32.879
5Y25.4680.023+25.445
10Y39.6100.023+39.587

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Thyrocare is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 7.77 means the investor is paying ₹7.77 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Thyrocare Technologies Ltd:

  • The EOD is 4.911. Neutral. Compare to industry.
  • The MRQ is 7.774. Seems overpriced? -1
  • The TTM is 7.774. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD4.911MRQ7.774-2.862
MRQ7.774TTM7.7740.000
TTM7.774YOY11.174-3.400
TTM7.7745Y7.945-0.172
5Y7.94510Y5.464+2.481
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD4.9112.021+2.890
MRQ7.7742.205+5.569
TTM7.7743.188+4.586
YOY11.1744.346+6.828
5Y7.9453.414+4.531
10Y5.4643.056+2.408
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Thyrocare Technologies Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--18.72418.7240%11.415+64%4.763+293%11.059+69%
Book Value Growth--1.2321.2320%1.165+6%1.062+16%1.139+8%
Book Value Per Share--99.53499.5340%80.810+23%82.921+20%73.076+36%
Book Value Per Share Growth--1.2321.2320%1.164+6%1.065+16%1.138+8%
Current Ratio--4.1854.1850%2.504+67%4.435-6%7.799-46%
Debt To Asset Ratio--0.1330.1330%0.217-39%0.145-8%0.124+8%
Debt To Equity Ratio--0.1540.1540%0.277-44%0.177-13%0.147+4%
Dividend Per Share--14.99114.9910%9.993+50%13.009+15%9.656+55%
Dividend Per Share Growth--1.5001.5000%0.400+275%1.731-13%1.587-5%
Eps--33.29533.2950%21.400+56%20.981+59%15.553+114%
Eps Growth--1.5561.5560%1.279+22%1.396+11%1.299+20%
Free Cash Flow Per Share--14.28614.2860%16.600-14%16.781-15%12.723+12%
Free Cash Flow Per Share Growth--0.8610.8610%0.556+55%1.240-31%1.267-32%
Free Cash Flow To Equity Per Share--14.28614.2860%16.600-14%4.621+209%3.059+367%
Free Cash Flow To Equity Per Share Growth--0.8610.8610%14.441-94%-10.163+1281%-5.613+752%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--143.977--------
Intrinsic Value_10Y_min--123.376--------
Intrinsic Value_1Y_max--14.349--------
Intrinsic Value_1Y_min--13.943--------
Intrinsic Value_3Y_max--43.173--------
Intrinsic Value_3Y_min--40.773--------
Intrinsic Value_5Y_max--72.069--------
Intrinsic Value_5Y_min--66.169--------
Net Profit Margin--0.2990.2990%0.229+31%0.241+24%0.245+22%
Operating Margin----0%-0%0.201-100%0.266-100%
Operating Ratio--0.9470.9470%1.046-9%0.961-2%0.988-4%
Pb Ratio4.911-58%7.7747.7740%11.174-30%7.945-2%5.464+42%
Pe Ratio14.683-58%23.23923.2390%42.194-45%32.428-28%27.987-17%
Peg Ratio--14.93714.9370%32.992-55%25.468-41%39.610-62%
Price Per Share488.850-58%773.750773.7500%902.950-14%659.320+17%445.811+74%
Price To Total Gains Ratio14.499-58%22.94922.9490%42.177-46%49.687-54%49.913-54%
Profit Growth--1.5571.5570%1.280+22%1.220+28%1.200+30%
Quick Ratio--3.3853.3850%1.595+112%3.158+7%6.077-44%
Return On Assets--0.2900.2900%0.207+40%0.212+37%0.186+56%
Return On Equity--0.3350.3350%0.265+26%0.249+34%0.217+54%
Revenue Growth--1.1911.1910%1.142+4%1.140+4%1.188+0%
Total Gains Per Share--33.71633.7160%21.408+57%17.772+90%20.715+63%
Total Gains Per Share Growth--1.5751.5750%1.781-12%1.458+8%1.173+34%
Usd Book Value--63714970.00063714970.0000%51700880.000+23%53213864.000+20%46920559.889+36%
Usd Book Value Change Per Share--0.2270.2270%0.138+64%0.058+293%0.134+69%
Usd Book Value Per Share--1.2041.2040%0.978+23%1.003+20%0.884+36%
Usd Dividend Per Share--0.1810.1810%0.121+50%0.157+15%0.117+55%
Usd Eps--0.4030.4030%0.259+56%0.254+59%0.188+114%
Usd Free Cash Flow--9145180.0009145180.0000%10620170.000-14%10757408.200-15%5976337.889+53%
Usd Free Cash Flow Per Share--0.1730.1730%0.201-14%0.203-15%0.154+12%
Usd Free Cash Flow To Equity Per Share--0.1730.1730%0.201-14%0.056+209%0.037+367%
Usd Price Per Share5.915-58%9.3629.3620%10.926-14%7.978+17%5.394+74%
Usd Profit--21312940.00021312940.0000%13691150.000+56%13457983.000+58%10355623.667+106%
Usd Revenue--71252060.00071252060.0000%59849020.000+19%55076901.000+29%42451976.111+68%
Usd Total Gains Per Share--0.4080.4080%0.259+57%0.215+90%0.251+63%
 EOD+3 -2MRQTTM+0 -0YOY+32 -95Y+33 -910Y+32 -10

3.2. Fundamental Score

Let's check the fundamental score of Thyrocare Technologies Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1514.683
Price to Book Ratio (EOD)Between0-14.911
Net Profit Margin (MRQ)Greater than00.299
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.385
Current Ratio (MRQ)Greater than14.185
Debt to Asset Ratio (MRQ)Less than10.133
Debt to Equity Ratio (MRQ)Less than10.154
Return on Equity (MRQ)Greater than0.150.335
Return on Assets (MRQ)Greater than0.050.290
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of Thyrocare Technologies Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose488.550
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets6,076,600
Total Liabilities810,900
Total Stockholder Equity5,265,700
 As reported
Total Liabilities 810,900
Total Stockholder Equity+ 5,265,700
Total Assets = 6,076,600

Assets

Total Assets6,076,600
Total Current Assets2,700,200
Long-term Assets2,700,200
Total Current Assets
Cash And Cash Equivalents 136,300
Short-term Investments 1,252,100
Net Receivables 932,000
Inventory 245,300
Other Current Assets 112,800
Total Current Assets  (as reported)2,700,200
Total Current Assets  (calculated)2,678,500
+/- 21,700
Long-term Assets
Goodwill 1,002,800
Intangible Assets 8,300
Long-term Assets Other 34,000
Long-term Assets  (as reported)3,376,400
Long-term Assets  (calculated)1,045,100
+/- 2,331,300

Liabilities & Shareholders' Equity

Total Current Liabilities645,200
Long-term Liabilities165,700
Total Stockholder Equity5,265,700
Total Current Liabilities
Accounts payable 165,300
Other Current Liabilities 111,700
Total Current Liabilities  (as reported)645,200
Total Current Liabilities  (calculated)277,000
+/- 368,200
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt207,000
Long-term Liabilities  (as reported)165,700
Long-term Liabilities  (calculated)207,000
+/- 41,300
Total Stockholder Equity
Retained Earnings 3,568,800
Total Stockholder Equity (as reported)5,265,700
Total Stockholder Equity (calculated)3,568,800
+/- 1,696,900
Other
Capital Stock529,000
Common Stock Shares Outstanding 52,903
Net Invested Capital 5,265,700
Net Working Capital 2,055,000



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
2,457,310
3,292,180
4,096,740
4,358,050
4,789,860
4,747,200
4,693,300
5,458,000
6,076,600
6,076,6005,458,0004,693,3004,747,2004,789,8604,358,0504,096,7403,292,1802,457,310
   > Total Current Assets 
1,287,500
1,106,720
1,344,030
1,495,340
1,424,000
1,360,200
1,522,500
2,381,300
2,700,200
2,700,2002,381,3001,522,5001,360,2001,424,0001,495,3401,344,0301,106,7201,287,500
       Cash And Cash Equivalents 
119,020
50,750
102,950
115,880
98,200
96,000
110,600
132,000
136,300
136,300132,000110,60096,00098,200115,880102,95050,750119,020
       Short-term Investments 
1,013,920
843,010
916,310
1,014,820
1,022,020
746,400
690,300
1,070,200
1,252,100
1,252,1001,070,200690,300746,4001,022,0201,014,820916,310843,0101,013,920
       Net Receivables 
49,060
64,140
140,760
133,930
99,300
124,600
172,600
446,800
932,000
932,000446,800172,600124,60099,300133,930140,76064,14049,060
       Inventory 
62,950
73,660
175,160
150,800
189,000
196,700
227,800
233,600
245,300
245,300233,600227,800196,700189,000150,800175,16073,66062,950
       Other Current Assets 
39,730
65,960
380
-10
18,500
234,500
335,000
28,400
112,800
112,80028,400335,000234,50018,500-1038065,96039,730
   > Long-term Assets 
0
0
0
2,894,780
3,365,920
3,387,000
3,170,800
3,076,600
3,376,400
3,376,4003,076,6003,170,8003,387,0003,365,9202,894,780000
       Property Plant Equipment 
929,020
1,546,290
1,523,760
1,686,150
1,901,800
1,872,500
1,725,800
0
0
001,725,8001,872,5001,901,8001,686,1501,523,7601,546,290929,020
       Goodwill 
0
453,430
1,068,580
1,068,580
1,068,580
1,068,600
1,002,800
1,002,800
1,002,800
1,002,8001,002,8001,002,8001,068,6001,068,5801,068,5801,068,580453,4300
       Long Term Investments 
176,150
16,150
16,150
0
200,000
206,600
0
0
0
000206,600200,000016,15016,150176,150
       Intangible Assets 
8,590
15,900
12,620
6,470
17,070
16,600
11,600
9,700
8,300
8,3009,70011,60016,60017,0706,47012,62015,9008,590
       Long-term Assets Other 
0
0
0
2,894,780
68,700
14,800
0
100
34,000
34,000100014,80068,7002,894,780000
> Total Liabilities 
394,680
168,350
440,640
290,220
356,960
396,000
1,026,700
1,185,200
810,900
810,9001,185,2001,026,700396,000356,960290,220440,640168,350394,680
   > Total Current Liabilities 
64,080
73,000
314,060
176,190
203,000
205,900
816,900
951,000
645,200
645,200951,000816,900205,900203,000176,190314,06073,00064,080
       Short-term Debt 
250,000
0
0
72,500
5,480
0
0
0
0
00005,48072,50000250,000
       Short Long Term Debt 
250,000
0
0
72,500
5,480
0
0
0
0
00005,48072,50000250,000
       Accounts payable 
15,140
8,350
20,240
12,960
65,900
75,100
218,600
250,100
165,300
165,300250,100218,60075,10065,90012,96020,2408,35015,140
       Other Current Liabilities 
32,150
35,130
229,800
55,450
90,100
71,300
481,900
272,000
111,700
111,700272,000481,90071,30090,10055,450229,80035,13032,150
   > Long-term Liabilities 
0
0
0
126,030
154,080
190,100
209,800
234,200
165,700
165,700234,200209,800190,100154,080126,030000
       Capital Lease Obligations 
0
0
0
0
0
0
99,400
84,900
207,000
207,00084,90099,400000000
       Long-term Liabilities Other 
0
0
0
74,500
0
0
46,300
43,900
0
043,90046,3000074,500000
> Total Stockholder Equity
2,062,630
2,763,720
3,656,100
4,067,830
4,432,900
4,351,200
3,666,600
4,272,800
5,265,700
5,265,7004,272,8003,666,6004,351,2004,432,9004,067,8303,656,1002,763,7202,062,630
   Common Stock
109,180
505,360
537,240
536,900
537,200
527,900
528,400
0
0
00528,400527,900537,200536,900537,240505,360109,180
   Retained Earnings 
1,728,470
1,959,550
1,858,950
1,982,480
2,278,200
2,806,900
2,101,800
2,599,200
3,568,800
3,568,8002,599,2002,101,8002,806,9002,278,2001,982,4801,858,9501,959,5501,728,470
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity 
4,090
9,240
26,980
325,770
345,300
365,600
364,000
0
0
00364,000365,600345,300325,77026,9809,2404,090



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue5,888,600
Cost of Revenue-1,696,900
Gross Profit4,191,7004,191,700
 
Operating Income (+$)
Gross Profit4,191,700
Operating Expense-3,878,400
Operating Income2,010,200313,300
 
Operating Expense (+$)
Research Development-
Selling General Administrative386,800
Selling And Marketing Expenses-
Operating Expense3,878,400386,800
 
Net Interest Income (+$)
Interest Income7,100
Interest Expense-23,700
Net Interest Income-16,600-16,600
 
Pretax Income (+$)
Operating Income2,010,200
Net Interest Income-16,600
Other Non-Operating Income Expenses-
Income Before Tax (EBT)2,277,2002,010,200
EBIT - interestExpense = -23,700
1,761,400
1,785,100
Interest Expense23,700
Earnings Before Interest and Taxes (ebit)-2,300,900
Earnings Before Interest and Taxes (ebitda)2,639,600
 
After tax Income (+$)
Income Before Tax2,277,200
Tax Provision-515,800
Net Income From Continuing Ops1,761,4001,761,400
Net Income1,761,400
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-16,600
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
PWASML.BSE
1 minute ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PWASML.BSE.

PWASML.BSE Daily Candlestick Chart
PSB.NSE
3 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PSB.NSE.

PSB.NSE Daily Candlestick Chart
PRIVISCL.BSE
3 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PRIVISCL.BSE.

PRIVISCL.BSE Daily Candlestick Chart
PRIVISCL.NSE
4 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PRIVISCL.NSE.

PRIVISCL.NSE Daily Candlestick Chart
PRINCEPIPE.NSE
5 minutes ago

I found you a Golden Cross on the daily chart of PRINCEPIPE.NSE.

PRINCEPIPE.NSE Daily Candlestick Chart
JIHD.JK
7 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JIHD.JK.

JIHD.JK Daily Candlestick Chart
INCI.JK
13 minutes ago

I found you a Death Cross on the daily chart of INCI.JK.

INCI.JK Daily Candlestick Chart
IMAS.JK
13 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IMAS.JK.

IMAS.JK Daily Candlestick Chart
FIRE.JK
21 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of FIRE.JK.

FIRE.JK Daily Candlestick Chart
PGFOILQ.BSE
21 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PGFOILQ.BSE.

PGFOILQ.BSE Daily Candlestick Chart
APII.JK
33 minutes ago

I found you a Death Cross on the daily chart of APII.JK.

APII.JK Daily Candlestick Chart
AIMS.JK
35 minutes ago

I found you a Golden Cross on the daily chart of AIMS.JK.

AIMS.JK Daily Candlestick Chart
ADMF.JK
36 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ADMF.JK.

ADMF.JK Daily Candlestick Chart
NIACL.BSE
51 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of NIACL.BSE.

NIACL.BSE Daily Candlestick Chart
NIACL.NSE
52 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of NIACL.NSE.

NIACL.NSE Daily Candlestick Chart
NGIL.BSE
52 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of NGIL.BSE.

NGIL.BSE Daily Candlestick Chart
VAVA.XETRA
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of VAVA.XETRA.

VAVA.XETRA Daily Candlestick Chart
O39.SG
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of O39.SG.

O39.SG Daily Candlestick Chart
M44U.SG
1 hour ago

I found you a Golden Cross on the daily chart of M44U.SG.

M44U.SG Daily Candlestick Chart
F9D.SG
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of F9D.SG.

F9D.SG Daily Candlestick Chart
A7RU.SG
1 hour ago

I found you a Golden Cross on the daily chart of A7RU.SG.

A7RU.SG Daily Candlestick Chart
CHJ.SG
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CHJ.SG.

CHJ.SG Daily Candlestick Chart
PSE.VN
1 hour ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of PSE.VN.

PSE.VN Daily Candlestick Chart
QTXB.PINK
1 hour ago

I found you a MACD Bearish Reversal Divergence on the daily chart of QTXB.PINK.

QTXB.PINK Daily Candlestick Chart